Literature DB >> 12828543

Performance of Sahli and colour scale methods in diagnosing anaemia among school children in low prevalence areas.

Paolo Barduagni1, Ahmed Saad Ahmed, Filippo Curtale, Mohamed Raafat, Layla Soliman.   

Abstract

Our aim was to compare the performance of the Sahli and Colour Scale methods in diagnosing anaemia in school children, where the prevalence of anaemia is low and the haemoglobin level ranges from mild to moderate (8-11 g/dl). The study was conducted in February 2001, in Qena Governorate, Upper Egypt. The haemoglobin level measured by the two methods in each child were compared with the result obtained by using a portable haemoglobin photometer 'HemoCue'. A total of 149 school children were included in the study. Using HemoCue, 17.4% children were anaemic; using the Sahli method (SM), 66.4% children were anaemic; and using the Haemoglobin Colour Scale (HCS) method, 57.7% children were anaemic. Neither method detected any cases of severe anaemia (Hb < 7 g/dl). Both the Sahli and Colour Scale methods are sensitive but have low specificity, giving a high rate of false positive results. Both methods perform perform very similarly in haemoglobin measurement; they fulfil many of the criteria for their use at primary health care level and detect almost all cases of anaemia in a given population, even if the level of anaemia is mild. Standards for collection, handling and disposal of blood samples are guaranteed more easily by the HCS than the SM. Moreover, lay people can easily manage the HCS with success after brief training. We suggest to gradually replace the SM by the HCS method in primary health care (PHC) centres. Where anaemia levels are moderate to mild, the use of SM and HCS as tools to define anaemia prevalence might be limited, as they often label healthy individuals as anaemic. Both methods remain a useful diagnostic tool to confirm the diagnosis of clinically suspected anaemia in areas where the prevalence of anaemia is low and the haemoglobin level ranges from mild to moderate.

Entities:  

Mesh:

Year:  2003        PMID: 12828543     DOI: 10.1046/j.1365-3156.2003.01062.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  7 in total

Review 1.  Prevalence of Anaemia in Kerala State, Southern India - A Systematic Review.

Authors:  PuruShothama Suseela Rakesh
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  Assessing diagnostic accuracy of Haemoglobin Colour Scale in real-life setting.

Authors:  Pankaj P Shah; Shrey A Desai; Dhiren K Modi; Shobha P Shah
Journal:  J Health Popul Nutr       Date:  2014-03       Impact factor: 2.000

3.  Agreement between dried blood spots and HemoCue in Tamil Nadu, India.

Authors:  Reshma P Roshania; Rukshan V Mehta; Ashwini Shete; Rohini Bingewar; Sangeeta Kulkarni; Aprajit Mahajan; Grant Miller; Alessandro Tarozzi; Reynaldo Martorell
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

4.  Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon.

Authors:  Calvin Tonga; Helen Kuokuo Kimbi; Judith Kuoh Anchang-Kimbi; Hervé Nyabeyeu Nyabeyeu; Zacharie Bissemou Bissemou; Léopold G Lehman
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

Review 5.  Prevalence of Dihydrofolate reductase gene mutations in Plasmodium falciparum isolate from pregnant women in Nigeria.

Authors:  Olusola Ojurongbe; Bukola D Tijani; Adegboyega A Fawole; Oluwaseyi A Adeyeba; Juergen F Kun
Journal:  Infect Dis Rep       Date:  2011-12-16

6.  Validation of the WHO Hemoglobin Color Scale Method.

Authors:  Leeniyagala Gamaralalage Thamal Darshana; Deepthi Inoka Uluwaduge
Journal:  Anemia       Date:  2014-04-15

7.  A cross sectional study of anemia and iron deficiency as risk factors for arsenic-induced skin lesions in Bangladeshi women.

Authors:  Molly L Kile; Joycelyn M Faraj; Alayne G Ronnenberg; Quazi Quamruzzaman; Mahmudar Rahman; Golam Mostofa; Sakila Afroz; David C Christiani
Journal:  BMC Public Health       Date:  2016-02-16       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.